Insulin human

N/A

Report date: 2023/06/12 20:00:51

Base Information

Drug NameInsulin human
Drug Alias Name人源胰岛素Insuman ImplantableRecombinant human insulin (Sanofi Deutschland)Insuman Comb 25Insuman +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetic ComaDiabetes MellitusDiabetic Ketoacidosis +[4] 
Global Approved IndicationsDiabetic ComaDiabetes MellitusDiabetic Ketoacidosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1997/02/21
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi Deutschland
China Registration ClassN/A

Develop Information

Active CompaniesStanford UniversitySanofi-Aventis Deutschland Gmbh
Inactive CompaniesN/A
Active IndicationsDiabetic ComaDiabetes MellitusDiabetic Ketoacidosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A